alexa
Reach Us +1-947-333-4405

GET THE APP

Hedwig Roggendorf | OMICS International
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 1200

Journal of Infectious Diseases & Therapy received 1200 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
Share This Page

Hedwig Roggendorf

Department of Farm Animals, University of Zurich, Zurich, Switzerland

Biography

Dr. Hedwig Roggendorf is currently working in Department of Farm Animals, University of Zurich, Zurich, Switzerland . Dr. Hedwig Roggendorf has authored of many research articles  related to Medicine.  Dr. Hedwig Roggendorf is serving as an editorial member and reviewer of several international reputed journals. Dr. Hedwig Roggendorf has successfully completed Administrative responsibilities. Dr. Hedwig Roggendorf research interests includes Medicine.
Publications

Induction of Functional Control in Chronic Hepatitis B Patients with Low Level HBsAg Using a Combination of a PreS1/S2/S HBV Vaccine (Sci-BVacTM) and a Nucleoside Analogue

Background: Treatment regimens for chronic hepatitis B virus (HBV) infection are efficient in suppressing viral load and improving hepatocellular injury and its complications. However, current antiviral agents such as nucleos(t)ide analogues or interferon-alpha are inefficient to reconstitute immunologic control of a persistent HBV infection or med... Read More»

Hedwig Roggendorf, Adalbert Krawczyk, Monika Lindemann, Daniel Shouval, Thomas Michler, Michael Roggendorf and Guido Gerken

: J Infect Dis Ther 2019, 4:390

DOI: 10.4172/2332-0877.1000390

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top